NZXR Share Price Enquiry into Green Cross Health Limited

NZX Limited
Level 1, NZX Centre
11 Cable Street
PO Box 2959
Wellington 6140
New Zealand
Tel +64 4 472 7599
www.nzx.com

8 April 2019

Steve Browning
COO/CFO
Green Cross Health Limited

By email: steve.browning@greencrosshealth.co.nz


Dear Steve,

Price Enquiry

We write with respect to the continuous disclosure Listing Rules.

Listing Rule 3.1.1 (”the rule”) is set out in the Schedule attached to this letter. In summary,
this rule requires issuers to immediately disclose any Material Information to NZX Limited
(“NZX”). The rule provides limited exceptions to this obligation. Material Information does
not need to be disclosed where a reasonable person would not expect the information to
be disclosed and where the information is confidential and its confidentiality is maintained
and where one of five safe harbours applies.

The price of Green Cross Health Limited Ordinary Shares (“GXH”) has increased from
$0.99, being the market close price on 3 April 2019, to $1.13, being the market price at
16:13 on the date of this letter. This represents a jump of 14%.

Given this price increase, please advise NZX whether Green Cross Health Limited
continues to comply with Listing Rule 3.1.1.

Could you please provide NZX with an answer to the above question (email:
surveillance@nzx.com) before 09:30am on 9 April 2019.

Please provide your response to this letter in “PDF” format, and note that it will be
published in full to the market.


Yours sincerely,


Philip Solarz
Market Surveillance
04 495 2889

SCHEDULE

3.1 Disclosure of Material Information
3.1.1 Once an issuer becomes Aware of any Material Information relating to it, the Issuer
must:
a) Promptly and without delay release that Material Information through MAP, and
b) Not disclose any Material Information to the public, any other stock exchanges
(except as provided for in Rule 3.26.2(d)) or any other party without first releasing
that Material Information through MAP.

3.1.2 Rule 3.1.1 does not apply when:
(a) One or more of the following applies:
i) Release of the information would be a breach of the law,
ii) The information concerns an incomplete proposal or negotiation,
iii) The information contains matters of supposition or is insufficiently definite to
warrant disclosure
iv) The information is generated for internal management purposes, or
v) The information is a trade secret,
(b) The information is confidential and its confidentiality is maintained, and
(c) A reasonable person would not expect the information to be disclosed.

3.2 False Market
3.2.1 An Issuer must promptly and without delay release Material Information through
MAP to the extent necessary to prevent development or subsistence of a market
for its Quoted Financial Products which is materially influenced by false or
misleading information emanating from:
a. the Issuer or any Associated Person of the Issuer, or
b. other persons in circumstances in each case which would give such
information substantial credibility,
and which is of a reasonably specific nature whether or not Rule 3.1.2 applies.

NZX Limited
Level 1, NZX Centre
11 Cable Street
PO Box 2959
Wellington 6140
New Zealand
Tel +64 4 472 7599
www.nzx.com

---

9
th
April 2019

NZX Limited
PO Box 2959
Wellington 6140


Dear Sir/Madam,

We refer to your letter “Price Enquiry” dated 8
th
April 2019.

We confirm that as at the date of this letter, GXH continues to comply with its continuous disclosure
obligations under the NZX Listing Rule 3.1.


Yours faithfully,



Steve Browning
Group CFO